1. Home
  2. PDYN vs VCRE Comparison

PDYN vs VCRE Comparison

Compare PDYN & VCRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Palladyne AI Corp.

PDYN

Palladyne AI Corp.

SELL

Current Price

$4.10

Market Cap

280.2M

Sector

Industrials

ML Signal

SELL

Logo Vicore Pharma Holding AB American Depositary Shares

VCRE

Vicore Pharma Holding AB American Depositary Shares

N/A

Current Price

$9.28

Market Cap

271.7M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PDYN
VCRE
Founded
1983
2000
Country
United States
Sweden
Employees
N/A
N/A
Industry
Wholesale Distributors
Sector
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
280.2M
271.7M
IPO Year
2020
2026

Fundamental Metrics

Financial Performance
Metric
PDYN
VCRE
Price
$4.10
$9.28
Analyst Decision
Buy
Strong Buy
Analyst Count
4
2
Target Price
$10.75
★ $29.03
AVG Volume (30 Days)
★ 833.1K
24.1K
Earning Date
11-11-2026
11-05-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 108.86
N/A
EPS
N/A
★ N/A
Revenue
★ $5,246,000.00
N/A
Revenue This Year
$373.67
$101.29
Revenue Next Year
$61.05
$481.15
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$4.14
$7.88
52 Week High
$10.00
$14.01

Technical Indicators

Market Signals
Indicator
PDYN
VCRE
Relative Strength Index (RSI) 20.61 41.99
Support Level N/A $8.34
Resistance Level $6.95 $12.08
Average True Range (ATR) 0.23 0.88
MACD -0.11 0.02
Stochastic Oscillator 11.64 29.61

Price Performance

Historical Comparison
PDYN
VCRE

About PDYN Palladyne AI Corp.

Palladyne AI Corp is a software company focused on autonomy for robotic systems and solutions. Its artificial intelligence and machine learning software seeks to revolutionize the capabilities of robots, enabling them to observe, learn, reason, and act in structured and unstructured environments. AI and ML software platform of the company empowers robots to perceive variations or changes in the real-world environment, enabling them to autonomously maneuver and manipulate objects accurately in response. Palladyne AI software has wide application, including in industries such as automotive, aviation, construction, defense, general manufacturing, infrastructure inspection, logistics and warehousing.

About VCRE Vicore Pharma Holding AB American Depositary Shares

Vicore Pharma Holding AB is a clinical-stage biopharmaceutical company developing a new class of disease-modifying therapies for respiratory and fibrotic diseases, including idiopathic pulmonary fibrosis (IPF). Its main program, buloxibutid, is an oral angiotensin II type 2 receptor agonist that has received Orphan Drug and Fast Track designation from the U.S. Food and Drug Administration and is currently being evaluated in the 52-week Phase 2b ASPIRE trial in IPF. Currently, Vicore is operating mainly in Sweden.

Share on Social Networks: